These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 707125)

  • 1. Disposition and oxidative metabolism of antipyrine in the rat.
    Aarbakke J
    Acta Pharmacol Toxicol (Copenh); 1978 Jul; 43(1):64-8. PubMed ID: 707125
    [No Abstract]   [Full Text] [Related]  

  • 2. The absence of significant biliary excretion of antipyrine or its metabolites in humans.
    Wissel PS; Kappas A
    Clin Pharmacol Ther; 1987 Jan; 41(1):85-7. PubMed ID: 3802711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Its relationship to intrinsic clearance in vitro and microsomal membrane lipid composition.
    Buters JT; Zysset T; Reichen J
    Biochem Pharmacol; 1993 Sep; 46(6):983-91. PubMed ID: 8216358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of short-term water deprivation on antipyrine disposition.
    Prasad P; Jung D; Niazi S
    J Pharm Sci; 1985 Mar; 74(3):338-9. PubMed ID: 4009446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cytochrome P-450 mediated metabolism of antipyrine in the rat at different extents of fluosol-DA hemodilution.
    Shrewsbury RP; White LG
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):411-4. PubMed ID: 2343186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of flumethrin on hepatic drug-metabolizing enzymes and antipyrine disposition in rats.
    Anadón A; Martinez-Larrañaga MR; Diaz MJ; Bringas P; Fernandez MC; Martinez MA; Fernandez-Cruz ML
    Toxicol Appl Pharmacol; 1995 May; 132(1):14-8. PubMed ID: 7747277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antipyrine breath test in the rat: a pharmacokinetic model.
    Lockwood GF; Chenery RJ; Oldham HG; Standring P; Norman SJ
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):207-14. PubMed ID: 3149242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the method of fluosol-DA administration on antipyrine metabolism in the rat.
    Shrewsbury RP; White LG
    J Pharm Pharmacol; 1990 Nov; 42(11):813-6. PubMed ID: 1982312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipyrine metabolism in the rat by three hepatic monooxygenases.
    Inaba T; Lucassen M; Kalow W
    Life Sci; 1980 Jun; 26(23):1977-83. PubMed ID: 7401910
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic stress impairs oxidative metabolism and hepatic excretion of model xenobiotic substrates in the rat.
    Pollack GM; Browne JL; Marton J; Haberer LJ
    Drug Metab Dispos; 1991; 19(1):130-4. PubMed ID: 1673385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of moderate fluosol-DA hemodilution on gender specific metabolism of antipyrine.
    Shrewsbury RP; White LG
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):455-62. PubMed ID: 2781142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent pharmacokinetics of antipyrine in the rat.
    Pollack GM; Li RC; Shen DD
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal effects on antipyrine metabolite kinetics in Aroclor 1254-treated rats.
    Shaw PN; Houston JB
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):232-40. PubMed ID: 3087023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the immunomodulator tilorone on antipyrine disposition in the rat.
    Svensson CK
    J Pharm Sci; 1986 Oct; 75(10):946-8. PubMed ID: 3795024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of some benzimidazoles on the disposition of antipyrine and tolbutamide from the rat isolated perfused liver.
    Ward SA; Mihaly GW; Tjia JF; Back DJ
    J Pharm Pharmacol; 1985 Jan; 37(1):62-4. PubMed ID: 2858532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of fever on antipyrine oxidation in the rat.
    Aarbakke J; Gadeholt G; Olsen H
    Eur J Pharmacol; 1978 May; 49(1):31-7. PubMed ID: 658126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of formaldehyde by N-demethylation of antipyrine. Detection of formaldehyde in bile by 13C-NMR spectroscopy.
    Huetter P; Albert K; Bayer E; Zeller KP; Hartmann F
    Biochem Pharmacol; 1987 Sep; 36(17):2729-33. PubMed ID: 3632703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent effect of propafenone on in vivo drug metabolism in the rat.
    Chong MT; Svensson CK
    Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):147-56. PubMed ID: 3423421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.
    Palette C; Cordonnier P; Naline E; Advenier C; Pays M
    J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.